- Home
- /Borrelia burgdorferi Ab.IgG+IgM with reflex to immune blot panel
Borrelia burgdorferi Ab.IgG+IgM with reflex to immune blot panel
Screens for Lyme disease antibodies with automatic confirmation by immune blot if positive.
Why This Biomarker Matters
Detects Lyme disease at various stages. Early detection and antibiotic treatment prevent serious complications like arthritis and neurological problems from untreated infection.
Overview
This test screens for Lyme disease, caused by the bacterium Borrelia burgdorferi transmitted through tick bites. It detects IgM antibodies (early infection) and IgG antibodies (past or recent infection). If positive, the test automatically 'reflex' to an immune blot panel for confirmation, which is more specific. This two-step approach reduces false positives. Early Lyme disease causes flu-like symptoms and a distinctive rash, while late disease can affect joints, heart, and nerves. Diagnosis and early treatment are important.
Technical Information (LOINC Codes)
Standardized laboratory codes for this biomarker
62341-3PrimaryAvailable Lab Tests
Order tests that measure this biomarker